NBIX

Neurocrine Biosciences, Inc. Competitors

$49.015
*  
0.125
0.26%
Get NBIX Alerts
*Delayed - data as of May 25, 2017 9:56 ET  -  Find a broker to begin trading NBIX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    NBIX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Neurocrine Biosciences, Inc.

CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
BioTime, Inc.
BTX: AMEX
$ 3.31 0.04 ▲ 41,544 $ 3.31
$ 3.23
$ 4.005
$ 2.255
NE 367,000
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 80.05 0.30 ▲ 49,568 $ 80.425
$ 79.15
$ 100.40
$ 36.62
NE 3,269,642
Brainstorm Cell Therapeutics Inc.
BCLI: NASDAQ-CM
$ 4.0101 -0.06 ▼ 9,081 $ 4.04
$ 4.01
$ 5.10
$ 2.0601
NE 75,133
CASI Pharmaceuticals, Inc.
CASI: NASDAQ-CM
$ .9924 0.01 ▲ 131 $ .9924
$ .9924
$ 1.7599
$ .82
NE 59,740
Cellectis S.A.
CLLS: NASDAQ-GM
$ 24.30 -0.07 ▼ 1,140 $ 24.36
$ 24.25
$ 34.229
$ 16.09
NE 858,641
Cellular Biomedicine Group, Inc.
CBMG: NASDAQ-GM
$ 6.05 -0.05 ▼ 1,793 $ 6.10
$ 6.05
$ 15.95
$ 5.05
NE 86,461
Cel-Sci Corporation
CVM: AMEX
$ .0825 -0.01 ▼ 574,579 $ .088
$ .08
$ .55
$ .06
NE 18,961
Champions Oncology, Inc.
CSBR: NASDAQ-CM
$ 2.50 unch n/a
n/a
$ 4.79
$ 1.11
NE 27,445
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 112.44 -1.54 ▼ 883 $ 114.83
$ 112.44
$ 137.385
$ 96.99
28.98 3,056,681
Cidara Therapeutics, Inc.
CDTX: NASDAQ-GM
$ 6.725 0.03 ▲ 2,302 $ 6.85
$ 6.65
$ 12.95
$ 6.10
NE 113,020
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 20.075 -0.33 ▼ 54,789 $ 21.15
$ 20.05
$ 31.98
$ 14
NE 1,026,636
Compugen Ltd.
CGEN: NASDAQ-GM
$ 5.35 unch 4,024 $ 5.40
$ 5.30
$ 7.57
$ 3.60
NE 273,556
CRISPR Therapeutics AG
CRSP: NASDAQ-GM
$ 15.565 -0.09 ▼ 1,581 $ 15.84
$ 15.5015
$ 24.9992
$ 11.63
NE 622,569
Curis, Inc.
CRIS: NASDAQ-GM
$ 1.70 -0.01 ▼ 84,879 $ 1.74
$ 1.69
$ 3.72
$ 1.47
NE 238,933
CytRx Corporation
CYTR: NASDAQ-CM
$ .5161 0.01 ▲ 338,208 $ .522
$ .501
$ 3.276
$ .361
NE 60,550
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 34.49 0.17 ▲ 763 $ 34.49
$ 34.39
$ 37.98
$ 27.02
NE 1,700,288
Dimension Therapeutics, Inc.
DMTX: NASDAQ-GS
$ 1.226 0.00 ▲ 1,683 $ 1.226
$ 1.20
$ 10.47
$ 1.15
NE 30,704
Editas Medicine, Inc.
EDIT: NASDAQ-GS
$ 16.795 -0.43 ▼ 72,658 $ 17.26
$ 16.7432
$ 38.25
$ 12.43
NE 694,339
Eiger BioPharmaceuticals, Inc.
EIGR: NASDAQ-GM
$ 6.925 -0.08 ▼ 3,650 $ 6.95
$ 6.90
$ 23.10
$ 6.85
NE 57,941
Fate Therapeutics, Inc.
FATE: NASDAQ-GM
$ 3.64 0.04 ▲ 2,150 $ 3.64
$ 3.60
$ 5.68
$ 1.47
NE 150,700
Genetic Technologies Ltd
GENE: NASDAQ-CM
$ 1.0925 0.01 ▲ 25,493 $ 1.10
$ 1.09
$ 2.89
$ 1.04
NE 12,493
Genocea Biosciences, Inc.
GNCA: NASDAQ-GM
$ 6.03 0.05 ▲ 6,668 $ 6.055
$ 5.96
$ 7.29
$ 3.28
NE 171,885
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 64.29 -0.02 ▼ 588,840 $ 64.68
$ 64.26
$ 88.85
$ 63.88
6.8 84,031,337
Halozyme Therapeutics, Inc.
HALO: NASDAQ-GS
$ 12.75 -0.09 ▼ 46,064 $ 12.90
$ 12.6991
$ 15.20
$ 7.70
NE 1,654,491
Hemispherx BioPharma, Inc.
HEB: AMEX
$ .5499 unch 2,543 $ .5499
$ .545
$ 2.6352
$ .3921
NE 14,551